Connect with us

Business

F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works – The New York Times

Aducanumab, or Aduhelm, is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some…

Published

on

Article feature image
ADVERTISEMENT

Once the product is approved, the cats out of the bag, the horse is out of the barn, said Dr. G. Caleb Alexander, a member of the F.D.A. advisory committee, who is an internist, epidemiologist and expert on drug safety and effectiveness at the Johns Hopkins…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Louis Vuitton-owner LVMH believes the future of retail will be mostly in-store – CNBC
Article feature image
Europe’s first billion-dollar education start-up is a tutoring site backed by SoftBank, Tencent – CNBC
Article feature image
Dollar catches breath ahead of Powell testimony; bitcoin attempts recovery – Reuters